- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
June 30, 2014
The US Women & PrEP Working Group, SisterLove and AVAC hosted a webinar marking the two-year anniversary of the FDA licensing of Truvada as PrEP in the US.
This webinar provided an opportunity to share updates and resources in the field and discussed how far we’ve moved in getting women involved in the rollout of PrEP. The webinar reviewed what we know and don’t know about women's motivations and barriers to consider daily oral PrEP as an intervention. Speakers included Karen Hoover from the US CDC, Judy Auerbach from the University of California at San Francisco, Alan McCord from Project Inform, and moderator, Dazon Dixon Diallo of SisterLove and the US Women & PrEP Working Group.
Location
Webinar
